270 related articles for article (PubMed ID: 22051859)
41. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
Ejigu Y; Magnus JH; Sundby J; Magnus MC
Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.
Gilmore JC; Serghides L; Bendayan R
AIDS; 2021 Jan; 35(1):1-14. PubMed ID: 33048885
[TBL] [Abstract][Full Text] [Related]
43. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.
Ciaranello AL; Myer L; Kelly K; Christensen S; Daskilewicz K; Doherty K; Bekker LG; Hou T; Wood R; Francke JA; Wools-Kaloustian K; Freedberg KA; Walensky RP
PLoS One; 2015; 10(3):e0117751. PubMed ID: 25756498
[TBL] [Abstract][Full Text] [Related]
44. Exposure to antiretroviral agents during pregnancy does not alter bone status in infants.
Mora S; Giacomet V; Viganò A; Cafarelli L; Stucchi S; Pivetti V; Manfredini V; Puzzovio M; Zuccotti G
Bone; 2012 Jan; 50(1):255-8. PubMed ID: 22080170
[TBL] [Abstract][Full Text] [Related]
45. Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country.
Adler C; Haelterman E; Barlow P; Marchant A; Levy J; Goetghebuer T
PLoS One; 2015; 10(8):e0135375. PubMed ID: 26284528
[TBL] [Abstract][Full Text] [Related]
46. Pregnancy Profile and Infant Outcomes Among HIV Infected Women Who Delivered in Cipto Mangunkusumo Hospital.
Indarti J; Yunihastuti E; Kurniati N; Aprilia B; Pamungkas DT; Chiprion AT; Ginting MA; Rizal S; Dewi C; Handayani L
Acta Med Indones; 2020 Jan; 52(1):55-62. PubMed ID: 32291372
[TBL] [Abstract][Full Text] [Related]
47. Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
El Beitune P; Duarte G; Quintana SM; Figueiró-Filho EA; Marcolin AC; Abduch R
Braz J Infect Dis; 2004 Apr; 8(2):140-50. PubMed ID: 15361992
[TBL] [Abstract][Full Text] [Related]
48. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
49. Cardiovascular effects of HAART in infants and children of HIV-infected mothers.
Zareba KM; Lavigne JE; Lipshultz SE
Cardiovasc Toxicol; 2004; 4(3):271-9. PubMed ID: 15470274
[TBL] [Abstract][Full Text] [Related]
50. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
[TBL] [Abstract][Full Text] [Related]
51. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
52. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.
Heidari S; Mofenson L; Cotton MF; Marlink R; Cahn P; Katabira E
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):290-6. PubMed ID: 21602695
[TBL] [Abstract][Full Text] [Related]
53. In utero exposure to antiretroviral therapy: feasibility of long-term follow-up.
Hankin C; Lyall H; Willey B; Peckham C; Masters J; Tookey P
AIDS Care; 2009 Jul; 21(7):809-16. PubMed ID: 19504373
[TBL] [Abstract][Full Text] [Related]
54. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980
[TBL] [Abstract][Full Text] [Related]
55. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
[TBL] [Abstract][Full Text] [Related]
56. Active pediatric HIV case finding in Kenya and Uganda: A look at missed opportunities along the prevention of mother-to-child transmission of HIV (PMTCT) cascade.
Gill MM; Natumanya EK; Hoffman HJ; Okomo G; Taasi G; Guay L; Masaba R
PLoS One; 2020; 15(6):e0233590. PubMed ID: 32484815
[TBL] [Abstract][Full Text] [Related]
57. HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.
Lima YA; Reis MN; Cardoso LP; Stefani MM
BMJ Open; 2016 Jul; 6(7):e010837. PubMed ID: 27381205
[TBL] [Abstract][Full Text] [Related]
58. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
[TBL] [Abstract][Full Text] [Related]
59. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
[TBL] [Abstract][Full Text] [Related]
60. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
